Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Ligand Pharmaceuticals Incorporated
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. It does this by financing, licensing its technologies or both. It operates two infrastructure-light royalty-generating IP platform technologies. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled FDA-approved products, including Gilead’s Veklury, Amgen’s Kyprolis, Baxter’s Nexterone, and Acrotech Biopharma’s Evomela. Its NITRICIL platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a range of indications. Its technologies also include HepDirect, LTP and BEPro Technology Platform, and Pelican Expression Technology. It has multiple alliances, licenses and other business relationships with various pharmaceutical companies.
Find out what a historical investment in Ligand Pharmaceuticals Incorporated would be worth today using our LGND stock calculator.
Market Capitalisation
$4.36B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
50.21K
High today
$223.00
Low today
$215.67
Open price
$215.76
52-week high
$247.38
52-week low
$98.89
Ready to start your investing journey with Stake?
Open an accountHow do I buy LGND shares in Australia?
Buying LGND shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Ligand Pharmaceuticals Incorporated in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in LGND
What is the ticker symbol of Ligand Pharmaceuticals Incorporated?
The ticker symbol for Ligand Pharmaceuticals Incorporated is LGND.
How much is one share of LGND?
One share of LGND is valued at $220.99 as of 21 May 2026.
What is the market capitalisation of Ligand Pharmaceuticals Incorporated LGND?
As of 21 May 2026 Ligand Pharmaceuticals Incorporated has a market cap of $4.36B.
What is the P/E ratio of LGND?
The Price to Earnings ratio of LGND is 29.33.
What is the Earnings Per Share of LGND?
The Earnings Per Share of LGND is $7.42.
What is the 52-week high for Ligand Pharmaceuticals Incorporated stock?
The Ligand Pharmaceuticals Incorporated 52-week high stock price is $247.38.
What is the 52-week low for Ligand Pharmaceuticals Incorporated stock?
The Ligand Pharmaceuticals Incorporated 52-week low stock price is $98.89.
Can I buy LGND shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy LGND shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in LGND on Stake
- Buy LGND from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of LGND from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
LGND related stocks